Studies have shown that G6PC expression is low in gluconeogenic tissue tumors such as hepatocellular carcinoma and clear cell renal cell carcinoma [7, 8], but G6PC is overexpressed in nongluconeogenic tissue tumors such as ovarian cancer and glioblastoma [9, 10]. The gene discussed is G6PC1; the disease is ovarian carcinoma.